Advertisement
Screener

ImmuCell Corporation (ICCC) Investment Company Purchase Premium Per Share

2.0 / 5 stars · 44/111 Roast Me

ImmuCell Corporation Investment Company Purchase Premium Per Share

ImmuCell Corporation (ICCC) reported Investment Company Purchase Premium Per Share of $70.00 per share for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:InvestmentCompanyPurchasePremiumPerShare · last filed 2024-11-13

  • ImmuCell Corporation investment company purchase premium per share for the quarter ending 2024-03-31 was $70.00, a 0.00% change year-over-year.
  • ImmuCell Corporation investment company purchase premium per share for the quarter ending 2023-03-31 was $70.00.
  • ImmuCell Corporation investment company purchase premium per share for fiscal 2023 was $70.00.
Period endInvestment Company Purchase Premium Per Share 3 monthInvestment Company Purchase Premium Per Share 6 monthInvestment Company Purchase Premium Per Share 9 monthInvestment Company Purchase Premium Per Share 12 month
2024-09-30$70.00
10-Q · filed 2024-11-13
2024-06-30$70.00
10-Q · filed 2024-08-13
2024-03-31$70.00
10-Q · filed 2024-05-14
2023-12-31$70.00
10-K · filed 2024-04-01
2023-09-30$70.00
10-Q · filed 2023-11-13
2023-06-30$70.00
10-Q · filed 2023-08-10
2023-03-31$70.00
10-Q · filed 2023-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92